FB Nasdaq FB Facebook

Biotech Stocks Touching New Highs: Clovis Oncology (NASDAQ:CLVS), Vanda Pharmaceuticals (NASDAQ:VNDA), Insys Therapeutics (NASDAQ:INSY), Albany Molecular Research (NASDAQ:AMRI)

Clovis Oncology Inc. reported a fourth quarter loss of $0.92 per share after the bell Thursday, compared to the loss of $0.81 per share last year. Clovis Oncology Inc. (NASDAQ:CLVS) stock performance was 1.58% in last session and finished the day at $79.62. Traded volume was 0.00 shares in the last session and the average…

Read More

Facebook (NASDAQ FB) Stock Update: Snapchat to Start Selling Ads

In an important news for the Facebook (NASDAQ FB) Stock, Snapchat, Inc. plans to launch its Snapchat Discovery service by November of this year. The service will enable advertising and media companies to promote their products by sharing disappearing ads, news content, videos, and articles with Snapchat users. Snapchat plans to launch Snapchat Discovery, a…

Read More

Tech News

Tech Analysis & Market News

Skip to content ↓